Stay updated on RP2 Monotherapy and RP2 with Nivolumab Clinical Trial
Sign up to get notified when there's something new on the RP2 Monotherapy and RP2 with Nivolumab Clinical Trial page.

Latest updates to the RP2 Monotherapy and RP2 with Nivolumab Clinical Trial page
- Check5 days agoChange DetectedThe Record History now shows Revision: v3.5.4 as the current version, replacing Revision: v3.5.3 in the history.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe page’s displayed revision/version string was updated from v3.5.2 to v3.5.3, reflecting a site/UI software update rather than a change to the study record details.SummaryDifference0.1%

- Check34 days agoChange DetectedSponsor name updated to 'Replimune, Inc.' and a new revision 'Revision: v3.5.2' was added; the previous entries 'Replimune Inc.' and 'Revision: v3.5.0' were removed.SummaryDifference0.3%

- Check63 days agoChange DetectedA new revision v3.5.0 is added to the Study Record Versions, and the previous revision v3.4.3 is removed.SummaryDifference0.1%

- Check70 days agoChange DetectedThe study record history now includes a new revision entry: v3.4.3. The previous revision v3.4.2 has been removed.SummaryDifference0.1%

- Check77 days agoChange DetectedRecruitment status updated from Recruiting to Active, not recruiting. Added sections include Contacts/Locations, Oversight, and Study Status.SummaryDifference0.7%

Stay in the know with updates to RP2 Monotherapy and RP2 with Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RP2 Monotherapy and RP2 with Nivolumab Clinical Trial page.